| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |